These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5370591)

  • 1. [Appraisal of the methods of expressing lead concentrations and porphyrin precursors in the urine].
    Iliescu S; Stavri G; Freund S; Vasilíu A
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(4):955-60. PubMed ID: 5370591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of urinary porphyrin and its precursors in children. 3. Fluctuation of urinary porphyrin and its precursors and its correlation with physiological anemia in the newborn and infants].
    Aoki K
    Nihon Shonika Gakkai Zasshi; 1968 Jun; 72(6):717-22. PubMed ID: 5749506
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of glycine loading on Delta-Aminolevulinic acid (ALA) and porphobilinogen (PBG) excretion during starvation.
    Deleña S; Brown H
    Metabolism; 1969 Nov; 18(11):901-5. PubMed ID: 5350555
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of delta-aminolevulinic acid and porphobilinogen in urine, using ion exchange chromatography columns].
    Doss M; Schmidt A
    Z Klin Chem Klin Biochem; 1971 Mar; 9(2):99-102. PubMed ID: 5573981
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary hepatic prophyrias. Gene penetration, drug sensitivity and subdivision in the light of systematic family studies.
    With TK
    Acta Med Scand; 1969; 186(1-2):117-24. PubMed ID: 5807639
    [No Abstract]   [Full Text] [Related]  

  • 8. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neurological disorder in porphyria cutanea tarda.
    Asmal AC; Vinik AI; Joubert SM
    S Afr Med J; 1970 Jul; 44(27):781-4. PubMed ID: 4317550
    [No Abstract]   [Full Text] [Related]  

  • 10. [The value of biotoxicologic analysis of urine in workers chronically exposed to lead].
    Stanković M; Petrović L; Poleti D
    Arh Hig Rada Toksikol; 1969; 20(4):517-24. PubMed ID: 4992045
    [No Abstract]   [Full Text] [Related]  

  • 11. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.
    Miyagi K; Cardinal R; Bossenmaier I; Watson CJ
    J Lab Clin Med; 1971 Nov; 78(5):683-95. PubMed ID: 5128821
    [No Abstract]   [Full Text] [Related]  

  • 12. Conventional and preparative electrophoretic separation of some urinary porphyrins and porphyrin precursors.
    Fischl J; Eichhorn F; Ruttenberg A; Major C
    Clin Chem; 1970 Apr; 16(4):331-4. PubMed ID: 5442210
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions.
    Bossenmaier I; Cardinal R
    Clin Chem; 1968 Jul; 14(7):610-4. PubMed ID: 5663456
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between some parameters of lead absorption and lead intoxication.
    Waldron HA
    Br J Ind Med; 1971 Apr; 28(2):195-9. PubMed ID: 5572689
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of vitamin E on porphyrinuria induced by ethanol in the rat.
    Mezey E; Quartner J; Nair PP
    Biochem Med; 1971 Feb; 5(1):30-6. PubMed ID: 5131443
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnosis of industrial lead poisoning.
    Gibson SL; Mackenzie JC; Goldberg A
    Br J Ind Med; 1968 Jan; 25(1):40-51. PubMed ID: 5642647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary elimination of precursors of porphyrins in children with hemopathies, rickets and various cerebral diseases].
    Marchi AG
    Clin Pediatr (Bologna); 1966 Nov; 48(11):555-63. PubMed ID: 5996975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Normal values for the concentrations of porphyrins and porphyrin precursors].
    Goreczky L; Róth I; Breckner M
    Z Klin Chem Klin Biochem; 1968 Nov; 6(6):489-92. PubMed ID: 5723227
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
    Vogler WR; Galambos JT; Olansky S
    Am J Med; 1970 Sep; 49(3):316-21. PubMed ID: 5455563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary porphyrin pattern in lead poisoning].
    Schmidt D; Stich W
    Dtsch Med Wochenschr; 1972 Aug; 97(32):1176-80. PubMed ID: 5044648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.